Emil Lou, MD, PhD

@cancerassassin1

Physician-Scientist, GI Oncologist/Neuro-Oncologist, Edit-Board member. Research interests: intercellular communication in , .

Masonic Cancer Center, U of MN
ನವೆಂಬರ್ 2013 ಸಮಯದಲ್ಲಿ ಸೇರಿದ್ದಾರೆ

@cancerassassin1 ತಡೆಹಿಡಿಯಲಾಗಿದೆ

ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್‌ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್‌ಗಳನ್ನು ನೋಡುವುದು @cancerassassin1 ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.

  1. ಪಿನ್ ಮಾಡಿದ ಟ್ವೀಟ್
  2. Paper writing 101. #41: Talking up your results.

  3. Does Minneapolis have a problem retaining professionals of color?

  4. "GEA is notoriously heterogeneous;should additional samples be assessed/how many for HER2 status? There are no data”

  5. A new set of consensus guidelines for properly evaluating HER2 in Gastroesophageal Cancers -

  6. Influenza virus exploits tunneling nanotubes for cell-to-cell spread. - PubMed - NCBI

  7. Emil Lou, MD, PhD ಹಿಂಬಾಲಿಸಿದ್ದಾರೆ , ಮತ್ತು
    • @dodsbir

      The DoD SBIR/STTR programs fund $1.1 billion annually in R&D projects at small technology companies that serve a DoD need and have commercial applications.

    • @natBME

      News from the editors of Nature Biomedical Engineering, a journal for researchers, engineers and clinicians interested in human health. Launching in Jan 2017

  8. article in : Why you don't have to exercise every day

  9. . article on first prototype. As with any great product or idea, have to start somewhere.

  10. Committees are a death sentence for creativity because people are very adept at saying what’s wrong with an idea versus saying let’s try!

  11. Happy to distribute latest issue of in the Masonic Cancer Clinic - check out the latest issue online for articles.

    , , and 2 others
  12. What's cancer staging? Stage refers to the extent of cancer, such as how large the tumor is, and if it has spread:

  13. Check out our paper on use of surgical calculator in gyn onc .

  14. . article features NCATS and its work to repurpose existing drugs for new diseases.

  15. . releases first set of Project GENIE data () We wrote about the project & its goals:

  16. Don't forget: The art exhibit featuring work from community is on display through Jan. 31 at our !

  17. No. 23 on list of "52 Places to Go in 2017": - Painting a Midwestern city purple.

  18. Revamping and revising how we view, differentiate, and eventually treat molecular subtypes of esophageal cancer:

  19. Editorial in via oncology: How to Avoid Late Chemotherapy - factors to consider

ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.

Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.

    ಇದನ್ನೂ ಸಹ ನೀವು ಇಷ್ಟಪಡಬಹುದು

    ·